Chair of SIGA

Associate Professor Matthew Foote is currently the Co-Director of the Gamma Knife® Centre of Queensland, Princess Alexandra Hospital and Queensland State Lead Radiation Oncologist for Radiation Oncology Centres (ROC) which is part of the ICON Group.  Having completed his specialist training in Brisbane in 2009 he then undertook further sub-specialist training in Gamma Knife® radiosurgery, stereotactic radiotherapy and neuro-oncology at the world renowned Princess Margaret Hospital, Toronto.

Commencing at the Princess Alexandra Hospital in 2010 and Greenslopes Private Hospital in 2012,  A/Prof Foote has special interests in stereotactic brain and body radiotherapy, neuro-oncology, head and neck cancer and cutaneous (skin) cancer.  He is the Principle Investigator of international, national and local clinical trials in melanoma, non-melanoma skin cancer and neuro-oncology.  He is on the management and scientific committees of the Co-operative Trials Group for Neuro-oncology (COGNO) and is internationally recognised for his work in stereotactic body and brain radiotherapy, currently assisting in the establishment of stereotactic programs throughout Australia and South East Asia.

Deputy Chair of SIGA

Associate Professor Shankar Siva is a Radiation Oncologist and NHMRC fellow at the Peter Mac and leads the Stereotactic Ablative Body Radiotherapy (SABR) program and Australia's first dedicated SABR clinic. He completed his PhD with the Molecular Radiation Biology (Martin) Laboratory focusing on translational investigations in precision high-dose lung radiotherapy. He published the first original research from Australia on the use of the SABR technique.

Shankar leads multiple clinical trials in the treatment of lung and urological cancers at the Peter Mac, and is chair of three TransTasman Radiation Oncology Group (TROG) studies in the fields of oligometastases, lung and kidney cancers. He is Co-Chair of the TROG Genitourinary Group, is an executive member of Radiation Oncology Research Committee (RORC) of the Royal Australian and New Zealand College of Radiologists (RANZCR) and Management Advisory Committee (MAC) of the Australasian Lung Cancer Trials Group (ALTG) amongst other leadership roles. He has research interests in high-tech radiotherapy delivery, radiation biology and radiation immunology.

Treasurer of SIGA

Dr Cecelia Gzell has completed undergraduate degrees in both Medical Science (University of Sydney, 1998) and Medicine (University of Newcastle, 2003). She undertook Radiation Oncology Specialist training primarily at Royal Prince Alfred Hospital (2006-2011) prior to becoming a fellow of the Royal Australian and New Zealand College of Radiologists (Faculty of Radiation Oncology) in 2011. She has since undertaken a post-graduate fellowship in Neuro-Oncology at Royal North Shore Hospital (2012-2014) with research and publications in the field of high-grade gliomas. This research is the foundation for a PhD thesis entitled: Optimising outcomes in patients with glioblastoma using radiotherapy(expected completion 2016).

Dr Gzell is involved in the Co-operative Trials Group for Neuro-Oncology (COGNO) and the Australian Genomics and Clinical Outcomes of Glioma Network (AGOG). She’s also a full member of the Society of Neuro-Oncology (SNO, USA). She joined Genesis CancerCare in 2014 as a general Radiation Oncologist with a particular interest in Neuro-Oncology. Her main focus is the best management of both primary and secondary central nervous system neoplasms - utilising modern techniques including stereotactic radiosurgery and gamma knife surgery.

a paragraph.